Methotrexate Completed Phase 4 Trials for Acute Lymphoblastic Leukaemias (ALL) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00853008Treatment of High Risk Adult Acute Lymphoblastic Leukemia
NCT00494897PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia
NCT00526409LAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic Leukemia
NCT00526175LAL-BR/2001: Study Treatment to Low Risk ALL
NCT01358253Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia